A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
2021-05-04 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
A case series of serious and unexpected adverse drug reactions under treatment with cariprazine
Heck, J.; Seifert, J.; Stichtenoth, D. O.; Schroeder, C.; Groh, A.; Szycik, G. R. & Degner, D. et al. (2021)
Clinical Case Reports, 9(5). DOI: https://doi.org/10.1002/ccr3.4084
Documents & Media
License
Details
- Authors
- Heck, Johannes; Seifert, Johanna; Stichtenoth, Dirk O.; Schroeder, Christoph; Groh, Adrian; Szycik, Gregor R.; Degner, Detlef; Adamovic, Ivana; Schneider, Michael; Glocker, Catherine; Rüther, Eckart; Bleich, Stefan; Grohmann, Renate; Toto, Sermin
- Abstract
- Abstract Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring (“black triangle” label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety. image - Issue Date
- 4-May-2021
- Journal
- Clinical Case Reports
- Language
- English
